Our laboratory has focused on the increased activity of an endogenous vascular elastase in the pathobiology of pulmonary hypertension and on the mechanisms by which it is upregulated and by which it orchestrates abnormal remodeling of the vessel wall, specifically the induction of growth factors, the induction of the glycoprotein tenascin, which amplifies the proliferative response, and fibronectin, which is critical to the process of smooth muscle migration in the context of neointimal formation. We explore strategies by which targetting these processes might arrest progression or induce regression of pulmonary vascular disease associated with unex¬ plained pulmonary hypertension. (CHEST 1998; (Fig 1, left) (Fig 1, left) . Infant rats injected with monocrotaline, unlike adult rats, show spontaneous regression of pulmonary hypertension, so it is of further interest that they do not show an increase in elastase activity following initial development of the structural changes. A cause-and-effect relationship between elastase and pulmonary vascular disease was pro¬ vided when elastase inhibitors45 were shown to be effective in attenuating the development and retard¬ ing the progression of pulmonary hypertension in monocrotaline-injected hypoxic rats (Fig 1, right) To determine how a pulmonary hypertensionproducing stimulus might invoke an increase in EVE activity, we carried out cell culture studies. These experiments were also helpful in elucidating how an increase in EVE might induce the proliferative and obliterative changes that subsequently occur in asso¬ ciation with progressive pulmonary hypertension (Fig 2) . We had proposed that structural and func¬ tional alterations in endothelium would result from
Increased Elastase Activity and
Pulmonary Hypertension TP he first clue that increased activity of an elasto--*-lytic enzyme might be important in the patho¬ physiology of pulmonary vascular disease was appar¬ ent following ultrastructural study of pulmonary arteries in lung biopsy tissue from patients with congenital heart defects.1 We observed that frag¬ mentation of the internal elastic lamina was associ¬ ated with endothelial abnormalities and clinical evi¬ dence of pulmonaiy hypertension. These features were also apparent in the pulmonary arteries of rats in which pulmonary hypertension was experimen¬ tally induced following injection of the toxin monocrotaline.2 We subsequently showed high elastin turnover through biochemical analyses of these pul¬ monary arteries, suggesting that degradation, as well as neosynthesis of elastin, was occurring and attrib¬ uted the degradation of elastin to increased activity of a serine elastase23 (Fig 1, left) . In both monocrotaline-and hypoxia-induced pulmonary hypertension in rats, increased activity of this enzyme was evident only 2 days after the inducing stimulus34 was intro¬ duced. The increase in enzyme activity was tran¬ sient4 in hypoxia-induced pulmonary hypertension, which is potentially reversible, whereas in the more malignant form of pulmonary hypertension induced by monocrotaline, an increase in elastase activity was *From the Division 
